Navigation Links
Compound from marine bacteria shows potential as multiple myeloma therapy

An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.

The experimental compound, NPI-0052, has been found to block or inhibit cancer cells' proteasomes from working effectively. The proteasome work as a cell's "garbage disposal," chewing up and disposing of old, unwanted proteins. With their proteasome jammed, cells die from the backup of damaged proteins.

"Proteasome inhibition is a key therapeutic target and bortezomib (Velcade tm) was the first in a new class of compounds in multiple myeloma. NPI-0052 is a novel proteasome inhibitor with a chemical structure and action that is distinct from bortezomib, and has the promise of being even more effective for patients," says Kenneth Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center at Dana-Farber, and senior author of the report.

The compound will be moved into Phase I clinical trials in early 2006, say officials of Nereus Pharmaceuticals in San Diego, the developer of NPI-0052. The compound will be tested as a single agent and subsequently in combination with other treatments.

Multiple myeloma is a currently incurable cancer of the bone marrow that causes a plunge in the production of vital red and white blood cells. Although relatively rare, it is the second most common type of blood cancer and accounts for 11,000 deaths annually in the United States. Bortezomib, approved by the Food and Drug Administration in 2003 for relapsed myeloma patients and subsequently for patients who have received at least one prior treatment, demonstrated in clinical trials that it extended the time to disease progression and also improved survival.

Though less toxic than conventional chemotherapy, bortezomib does have
'"/>

Source:Dana-Farber Cancer Institute


Page: 1 2 3

Related biology news :

1. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
2. Newly Discovered Compound Blocks Known Cancer-Causing Protein
3. Compounds in plastic packaging act as environmental estrogens altering breast genes
4. Compound might defeat African sleeping sickness, clinical trial beginning this month
5. Compound from Chinese medicine shows promise in head and neck cancer
6. Anti-cancer Compound In Beer Gaining Interest
7. Compound in dairy products targets diabetes
8. Compound eyes, evolutionary ties
9. Sequencing of marine bacterium will help study of cell communication
10. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
11. UN environmental agency steps up battle against marine pollution
Post Your Comments:
(Date:7/24/2008).... Fire suppression may have reduced carbon storage...ion since the early twentieth century has caused a...ller trees, and the density of stems growing on tr...e created thicker forests and are thought to accou...ter quantify changes in aboveground biomass, Fello...
(Date:7/23/2008)...UCLA "world summit" will bring together internatio...ding the U.S., Russia, China, Japan, Australia and...om July 27 to Aug. 2. , "We are bringing toge...ncient life," said summit organizer J. William Sch... Geophysics and Planetary Physics, Center for the ...
(Date:7/23/2008)...A University of Washington study of top-selling la...ts emitted dozens of different chemicals. All six ...ulated as toxic or hazardous under federal laws, b...ct labels. , "I first got interested in this topi...heners in public restrooms and the scent from laun...
(Date:7/23/2008)...th less than a month remaining before the Beijing ...es of measures to improve air quality for the Game...ty to allow the Chinese to monitor the effectivene...se problems for the Olympic athletes and hinder th...ance sports, such as cycling and marathons. ,Si...
Breaking Biology News(10 mins):AGU journal highlights -- July 23, 2008 2AGU journal highlights -- July 23, 2008 3AGU journal highlights -- July 23, 2008 4AGU journal highlights -- July 23, 2008 5AGU journal highlights -- July 23, 2008 6AGU journal highlights -- July 23, 2008 7AGU journal highlights -- July 23, 2008 8UCLA 'world summit' to explore ancient life on Earth, and beyond 2Toxic chemicals found in common scented laundry products, air fresheners 2Toxic chemicals found in common scented laundry products, air fresheners 3Air quality forecasts for China 2WellPoint Partners With CareNex Health Services to Expand Its Neonatal Intensive Care Services Program 23927 1WellPoint Partners With CareNex Health Services to Expand Its Neonatal Intensive Care Services Program 23927 2Lance Armstrong Foundation to Welcome Senator John McCain to LIVESTRONG 28TM 29 Cancer Summit 23922 1Lance Armstrong Foundation to Welcome Senator John McCain to LIVESTRONG 28TM 29 Cancer Summit 23922 2Aiming to improve schizophrenia treatment through the NIMH CNTRICS Initiative 23918 1Aiming to improve schizophrenia treatment through the NIMH CNTRICS Initiative 23918 2Aiming to improve schizophrenia treatment through the NIMH CNTRICS Initiative 23918 3Farming at young age may lead to bone disease in adulthood 23913 1Farming at young age may lead to bone disease in adulthood 23913 2
...nt, pathogenic bacteria on uncooked poultry produc...d to antibiotic use in production, according to re... Public Health. Their study is the first to direct...ucts sold in U.S. supermarkets from food producers... do not. The study focused on antibiotic resistanc...
...ey of gene activity in the X chromosomes of women ...g individuals, according to new work by researcher...nces & Policy (IGSP) and Pennsylvania State Un...tions for understanding the differences in traits ...s of both health and disease, said Huntington Will...
...ity and the University of Maryland have identified...,s fastest-evolving invertebrate. , Finicky matin...the speedy speciation of the Laupala cricket, the ...gazine. , Females in the Laupala genus detect tin... songs, which differ from one Laupala species to t...
...its patients miserable and debilitated with chroni... affected by the disease face possible paralysis o...ease frustrates doctors because there,s no effecti...identified more than a decade ago. Currently littl... people than cystic fibrosis, hereditary muscular ...
Other Biology News:Drug-resistant bacteria on poultry products differ by brand 2Drug-resistant bacteria on poultry products differ by brand 3Variation in women's X chromosomes may explain differences among individuals, between sexes 2Variation in women's X chromosomes may explain differences among individuals, between sexes 3Cricket's finicky mating behavior boosts biodiversity 2Cricket's finicky mating behavior boosts biodiversity 3Potential treatments for neurofibromatosis 2Potential treatments for neurofibromatosis 3
(Date:7/24/2008)...re/ -- The Global Probiotics Council,(GPC), a comm...ult Honsha,Co., Ltd., announced the two awardees w...rant for Probiotics Research (YIGPRO) today. The p...who will continue to contribute to,the advancement...United,States., Ajay S. Gulati, MD, an Assistant ...
(Date:7/24/2008)... Important Advance in Radiofrequency ...if., July 24 /- PEAK Surgical, Inc., ...tissue dissection system,based on a proprietary te...rug Administration has granted the company 510(k) ... use in general surgery. The PEAK Surgery System,c...
(Date:7/24/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched ceftazidime for injectio...m antibiotic. Sagent will offer ceftazidime in 1,a...ge vials. According to,IMS data, 2007 sales of inj...ximately $45.7 million., "Sagent is proud to be p...
(Date:7/24/2008)...swire-FirstCall/ -- United,Therapeutics Corporatio...lease its 2008 second quarter financial results be...., United Therapeutics will host a half-hour tele.... Eastern Time. The teleconference is accessible,b...rs dialing,1-706-679-8129. A rebroadcast of the te...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
... Madison, Wis. -- Bruker AXS Inc. , the Madison-b...aunched a bevy of products at the PITTCON 2004 i...ew technology to quickly produce protein crystal s... dispersive X-ray spectrometer and SuperSpeedSolut...s designed to simplify and automate protein crysta...
... Madison, Wis. -- Promega Corporation and EraGe...panies, signed a licensing agreement Wednesday all...search assays. The partnership also grants Promega..., ,Promega should expect rapid market acceptance a... market presence by Promega will further enhance E...
... When senior management use phrases like best prac...ile this may be no more than an observation of a s...n in every organization where those topics come up...slackers, it makes sense to pay attention to this ... the response is probably some unique combination ...
... MILWAUKEE- Technology transfer and commercializat...g last week,s announcement by the Medical College ...y transfer, the Madison Development Corporation ...novation (CATI) have announced a new partnership ...ransfer in the Madison area. We Energies is also h...
Other Biology Technology:Bruker AXS launches new products at PITTCON 2004 2The cultural impact of best practice and world class theories 2The cultural impact of best practice and world class theories 3Madison Development Corp. and CATI form tech transfer partnership 2
Synthetic Peptide Synthesis from rPeptide, LLC
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies.
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)
PP2B-Abeta (C-20)
Biology Products: